Johnson & Johnson MedTech announced today that it launched its CereGlide 42 and CereGlide 57 aspiration catheters in the U.S. The medtech giant also launched the InnerGlide 7 delivery aid, rounding out the newest additions to its aspiration-first stroke portfolio. J&J MedTech said the devices complete the CereGlide family, which … [Read more...] about Johnson & Johnson Medtech launches new CereGlide aspiration catheters in US
johnson & johnson medtech
The biggest cardiac tech news out of the 2026 AF Symposium
Last week, the leading developers of treatments for atrial fibrillation (AFib) convened in Boston for the 2026 AF Symposium. At the event, the makers of technologies like pulsed field ablation (PFA) systems, left atrial appendage (LAA) devices, heart access catheters and more offered insights into how their therapies contribute to the treatment … [Read more...] about The biggest cardiac tech news out of the 2026 AF Symposium
Johnson & Johnson MedTech has encouraging Omnypulse results, more data backs Varipulse
Johnson & Johnson MedTech [WtwhTicker symbol="JNJ"](NYSE: JNJ)[/WtwhTicker] today announced 12-month pilot data from a study of its investigational Omnypulse platform for AFib. The Omnypulse platform features the Omnypulse catheter and the Trupulse generator. The company offers the catheter as a large-tip, 12 mm device with Carto 3 mapping … [Read more...] about Johnson & Johnson MedTech has encouraging Omnypulse results, more data backs Varipulse
Johnson & Johnson MedTech announces updates to Varipulse, new ultrasound catheter
Johnson & Johnson MedTech [WtwhTicker symbol="JNJ"](NYSE: JNJ)[/WtwhTicker] today announced the full commercial release of its NuVision Nav ultrasound catheter. Additionally, the company announced the introduction of the Varipulse Plus platform. Varipulse Plus represents an update to the existing Varipulse pulsed field ablation (PFA) … [Read more...] about Johnson & Johnson MedTech announces updates to Varipulse, new ultrasound catheter
HRS launches data registry for PFA that treats AFib, J&J announces sponsorship
Johnson & Johnson MedTech today announced its sponsorship of a new PFA data collection platform from the Heart Rhythm Society (HRS). HRS aims to capture real-world data on pulsed field ablation (PFA) procedures used to treat AFib. The first-of-its-kind registry will offer a long-term data collection platform, J&J MedTech said in a news … [Read more...] about HRS launches data registry for PFA that treats AFib, J&J announces sponsorship
Medtronic, J&J MedTech both get FDA nods for liquid embolic systems
Medtronic (NYSE: MDT) and Johnson & Johnson (NYSE: JNJ) have both announced recent regulatory milestones for liquid embolic systems. Both picked up FDA approvals for the treatment of symptomatic subacute and chronic subdural hematoma (cSDH) as an adjunct to surgery. Earlier this month, Medtronic said the FDA granted the indication for its … [Read more...] about Medtronic, J&J MedTech both get FDA nods for liquid embolic systems
CMS adds reimbursement for cardiac ablation in ASCs
The Centers for Medicare and Medicaid Services (CMS) has provided a major reimbursement update for cardiac ablation technologies. In its 2026 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule, CMS added cardiac catheter ablation procedures to its ASC-covered procedures list. This … [Read more...] about CMS adds reimbursement for cardiac ablation in ASCs
J&J’s Shockwave shares data supporting Javelin forward IVL
Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results in a study using its Javelin peripheral IVL catheter. Yesterday, the company shared findings from a separate intravascular lithotripsy (IVL) study. It presented findings at the annual Vascular InterVentional Advances (VIVA) meeting in Las Vegas. Today, it shared … [Read more...] about J&J’s Shockwave shares data supporting Javelin forward IVL
J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI
Johnson & Johnson MedTech‘s Shockwave Medical today announced one-year results supporting the use of its Shockwave peripheral IVL system. Shockwave shared findings from DISRUPT BTK II. The post-market study evaluates the safety and effectiveness of the company's intravascular lithotripsy (IVL) system for the treatment of calcified lesions … [Read more...] about J&J’s Shockwave reports positive IVL data for below-the-knee lesions, CLTI
Johnson & Johnson MedTech launches ventricular arrhythmia ablation registry
Johnson & Johnson MedTech today introduced the Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias (CORE-VA). The company announced the registry during the International Symposium on Ventricular Arrhythmias in Philadelphia. It aims to capture contemporary practice patterns in ventricular arrhythmia (VA). That includes … [Read more...] about Johnson & Johnson MedTech launches ventricular arrhythmia ablation registry
